Anti-aging Archives

In Depth 14 Feb 2024

The next leap in pet health: longevity drugs for dogs

Find out how we could stave off the heartbreak of saying goodbye to our dogs, as three longevity drugs for dogs could soon be approved.

February 14, 2024 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 16 Jan 2024

Five biotech companies taking Florida by storm

Check out five of the top Florida companies taking the state’s biotech industry by storm with their innovative technologies.

January 16, 2024 - 6 minutesmins - By Willow Shah-Neville

Best in Biotech 17 Oct 2023

Singapore’s biotech scene: six companies leading the way

Singapore set out to become a global biotech hub back in 2000, and, although still awaiting its big success story in the industry, it is currently a leading hub in the APAC region for R&D, biopharma manufacturing, and commercial operations, with a growing startup ecosystem that includes numerous biotech companies. In 2000, the government in […]

October 17, 2023 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 26 Sep 2023

Eight anti-aging startups on a mission to extend lives

The longevity biotech industry revolves around the goal of increasing the period of life that a person spends in good health. There has been a rapidly expanding effort in recent years to develop drugs that target aging as a root cause of disease, and this type of biotechnology has come to be a very popular […]

September 26, 2023 - 10 minutesmins - By Willow Shah-Neville

News and Trends 26 Jul 2023

Diabetes drug could promote healthy aging

A research team from the School of Public Health, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has provided genetic evidence that metformin might promote healthy aging using a cohort study of more than 300,000 participants of European descent (UK Biobank). The proof-of-concept work supports further clinical research into the drug repositioning […]

July 26, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 10 May 2023

Cell rejuvenation for age-related diseases

By Sharon Rosenzweig-Lipson, CSO, Life Biosciences Cellular rejuvenation is quickly becoming a hot topic in the development of novel therapeutic modalities for a range of diseases. The leading approaches to cellular rejuvenation currently in development utilize epigenetic reprogramming to achieve this goal. Epigenetics is the study of how positive and negative lifestyle factors (exercise, smoking, […]

May 10, 2023 - 3 minutesmins - By External Contributor

News and Trends 24 Apr 2023

Life Biosciences gene therapy data shows visual function restored in primates

Life Biosciences (Life Bio) has announced preclinical data in nonhuman primates (NHP) for its novel gene therapy candidate, which uses a partial epigenetic reprogramming approach to restore visual function. The approach has been shown to reverse aging, improve vision, and extend lifespan in mice, but whether epigenetic reprogramming would work in primates was not known. […]

April 24, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 15 Mar 2023

Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch

Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, has launched its new pipeline company, Amplifier Therapeutics. The organization will develop ATX-304, a pan-AMPK (AMP-activated protein kinase) activator. Amplifier has also acquired Betagenon AB, a Swedish biopharmaceutical company, which has discovered novel AMPK activators. It will continue its work […]

March 15, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 23 Dec 2022

Watch: Eva Hoffmann talks about genetics and fertility

Eva R. Hoffmann is the Professor in Molecular Genetics at the Department of Cellular and Molecular Medicine at the University of Copenhagen in Denmark. She is involved in the Molecular Aging Program, Medical Genetics Program and the Centre for Chromosome Stability. Hoffmann’s laboratory investigates the role of the DNA damage response and cell cycle proteins in […]

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Nov 2022

Hormone discovery could predict long term health of men

Researchers have discovered the vital role of INSL3, a hormone that develops in men during puberty, which provides an early prediction of whether they could develop certain diseases in later life. Scientists from the University of Nottingham in the U.K. have discovered that the novel insulin-like peptide hormone, INSL3, is consistent over long periods of […]

November 8, 2022 - 3 minutesmins - By Jim Cornall

longevity treatment bioAge Kristen Fortney

Interview 31 Oct 2022

AI and biobanks could open the way to longevity treatments

The development of longevity treatments is hampered by a lack of biomarkers and validated drug targets. BioAge’s co-founder and CEO, Kristen Fortney, explains how the firm is enlisting machine learning (ML), artificial intelligence (AI) and biobanks to fill in the gaps. The quest for human longevity treatments is attracting big cash in the biotech industry. […]

October 31, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 24 Aug 2022

BioAge partners with Age Labs to study healthy life length

BioAge Labs, Inc., a biotech company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, has partnered with Age Labs AS, a diagnostic company that develops tests for the early detection of age-related diseases. Under the terms of the agreement, BioAge will perform multi-omics analyses on samples and health records […]

August 24, 2022 - 3 minutesmins - By Jim Cornall

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us